GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aprogen Biologics Inc (XKRX:003060) » Definitions » Research & Development

Aprogen Biologics (XKRX:003060) Research & Development : ₩15,000 Mil (TTM As of Dec. 2023)


View and export this data going back to 1984. Start your Free Trial

What is Aprogen Biologics Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Aprogen Biologics's Research & Development for the three months ended in Dec. 2023 was ₩6,094 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was ₩15,000 Mil.


Aprogen Biologics Research & Development Historical Data

The historical data trend for Aprogen Biologics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aprogen Biologics Research & Development Chart

Aprogen Biologics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 336.12 697.70 1,735.39 2,186.85 14,999.89

Aprogen Biologics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 656.76 11,994.23 -6,689.30 3,600.92 6,094.05

Aprogen Biologics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩15,000 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aprogen Biologics  (XKRX:003060) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Aprogen Biologics Research & Development Related Terms

Thank you for viewing the detailed overview of Aprogen Biologics's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Aprogen Biologics (XKRX:003060) Business Description

Traded in Other Exchanges
N/A
Address
545, Dunchon-daero, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR
Aprogen Biologics Inc is specialized in manufacturing and selling various pharmaceutical products including amino acid infusion agents and antibiotics.

Aprogen Biologics (XKRX:003060) Headlines

No Headlines